We're excited to join AlamarBio's Precision Biomarker Summit this week in San Diego! 🧬 Sapient’s Tao Long will share insights on inflammatory profiles in obesity and how #NULISAseq reveals cytokine changes post-GLP-1 therapy. Still time to register: 🔗 alamarbio.com/precision-biom…

Great first day at #BIOMUK2025! Big thanks to everyone who joined Dr. Mo Jain’s talk & plenary panel - and to those who stopped by our booth to chat #multiomics. We’ll be back tomorrow, come see us at Booth 52! #BiomarkersandPrecisionMedicine #OGPremed #BiomarkersUK

“Proteins are where the action is.” DNA/RNA only go so far-proteins drive reactions, and metabolites tell the story." Our CEO Jonathan Usuka joined Qualio #LabtoLaunch to share how Sapient’s high-res #multiomics + AI is accelerating discovery. 🎧 sapient.bio/resources/mult…

Innovation alert! Sapient has been granted two U.S. patents for our novel #massspectrometry signal processing + data normalization tech - powering more accurate, scalable #biomarker discovery. sapient.bio/resources/mass…

Our team had great time last week at #BiomarkersandPrecisionMedicineUS2025! Awesome talks on #multiomics & how our DynamiQ database + biorepository advance biomarker research. Thanks to all who stopped by Booth & our poster on immune modulation in weight loss!

Outliers & missing data in #omics can complicate #biocomputational analysis — but also uncover hidden insights. Sapient’s Shreya Gaddam & Cameron Lamoreaux share strategies to handle missingness & outliers in large-scale #proteomics & #metabolomics data.🔗sapient.bio/resources/bioc…

Thank you to our engaged audience and the gracious hosts of the #PACTSummit for the opportunity for Dr. Jonathan Usuka to present on omics-driven innovations in drug discovery and development. #AnalyticalChemistry #PACTS #MultiOmics #Discovery

Last week we hosted a #PatentParty to mark a major milestone for Sapient, recognizing inventions behind our rLC-MS pipeline that advance the scale and accuracy of #biomarkerdiscovery ! More on our awarded patents: lnkd.in/dRHk3EPx

Marker of the Month ⚛️: Creatinine. A key kidney biomarker linked to #CKD, #T2D, cardiovascular & liver disease, but limited for early detection. With our DynamiQ™ Engine, we examined its disease ties and related metabolic markers. eBook ⬇️ sapient.bio/resources/crea…

Get more from your #FFPE samples. Turn archival tissue into a discovery engine. Sapient’s FFPE Proteomics measures 10,000+ proteins across key oncogenes, drug targets & pathways to unlock new #biomarker insights. ➡️ lnkd.in/gZpnpwgU

White Paper: MS-based #FFPE proteomics marks a turning point in oncology R&D. Direct quantification of tumor protein function -isoforms, PTMs, pathway activation, and resistance -without antibodies. Learn more: lnkd.in/gj28XfWF

AI in analytical science isn’t about hype-it’s about scale and context. #Multiomics + AI moves us beyond single biomarkers toward true systems-level disease models. Dr. Mo Jain discussed this with The Analytical Scientist: lnkd.in/gxMZreu3

Using large-scale #Metabolomics (1,600 samples), our #ML aging clock shows: • Accelerated aging in chronic disease • Severity-linked acceleration • Reversal after therapy (e.g., transplant) Case study: lnkd.in/grKqazn

Looking for a protein or target to modulate? Explore Sapient’s interactive Protein Assay Menu –12,000+ proteins by mass spectrometry: lnkd.in/gv7rm2GT Analyze proteins & PTMs across plasma, cells, and tissue (incl. FFPE). Search by protein, gene, pathway, or phenotype.

#Metabolomics reveals phenotypic differences missed by genes or labs. Sapient uncovers: • Therapy-response differences • Exposure-modified genetic risk • Biology behind phenotypic variation • Metabolic signals before disease #WhiteSheet: sapient.bio/resources/meta…

Unlock biomarker insights & responder profiles from #FFPE samples. Sapient’s FFPE Multi-Omics Platform analyzes archived tissue to: • Optimize stratification & dosing • Identify target engagement • Select responder subgroups #ClinicalOncology study: lnkd.in/ghg4qHSa

Did you know? Plasma metabolomics reveals system‑wide biology invisible to tissue‑specific markers. By capturing circulating metabolites from multiple organs, it enables a holistic view of physiology, disease, and biomarker discovery. 🔗 sapient.bio/resources/meta… #Metabolomics

“AI reveals structure in biological complexity that humans can’t define manually—and orthogonal validation is what makes those signals trustworthy.” — Mo Jain, MD PhD, in The Analytical Scientist #AI #Omics #Biomarkers 🔗lnkd.in/gYpwxUND

Upcoming Webinar | Proving Target Relevancy with FFPE Proteomics Learn how next‑gen FFPE proteomics delivers direct, functional human evidence to validate targets and reduce late‑stage failures in precision oncology. 🔗 Register to attend the live event: lnkd.in/g9Ec3tazy

Why do patients with the same diagnosis respond differently to the same drug? Because human biology is heterogeneous—and that complexity can’t be captured by genomics or single biomarkers alone. Learn more here 👉 sapient.bio/resources/meta… #AI #Metabolomics